REXPIPES.NS,0P0001N0L1,14000
REXPIPES · Chemicals · NSE
₹86
Current Market Price
Fair Value (DCF)
₹170
Margin of Safety
+97.9%
Updated 10h ago
YieldIQ Score
71/100
Piotroski F-Score
7/9
Economic Moat
Narrow
Confidence
33%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹81 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
—
Short-term liquidity
Asset Turnover
1.79×
Revenue per ₹ of assets
Revenue CAGR (3Y)
10.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹85.9
Bear case
₹83.87
MoS -2.4%
Base case
₹170.03
MoS +49.5%
Bull case
₹182.78
MoS +53.0%
Ratio Trends
Historical ratio trends for REXPIPES are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.
Historical Financials
Historical financials for REXPIPES are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.
Peer Comparison
Peers not yet ranked for REXPIPES. Comparable companies and side-by-side valuation will appear here once the peer set is established.
Dividend History
No dividend events recorded for REXPIPES in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of REXPIPES →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for REXPIPES →
Compare
Head-to-head with peers
Compare REXPIPES side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse REXPIPESNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.